Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 506820 | NSE: ASTRAZEN

Watchlist

NSE BSE

7599.00

06-Feb-2025

Open
High
Low
Previous Close

7500.00
7726.10
7499.85
7531.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

19590
1491.71
8139.00
4785.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,171.88
177.09
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,675.10
0.35%
24.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.62
9.27
17.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
8.85
16.44

PAT CAGR (%)

10 Years
5 Years
3 Years

-
17.47
37.89

P:E (Median)

8 Years
5 Years
3 Years

104.91
106.37
99.06

P:BV (Average)

8 Years
5 Years
3 Years

19.50
19.50
18.53

EV:EBITDA (Average)

8 Years
5 Years
3 Years

60.37
63.52
62.64

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 64.6
P/E Ratio 100.47
Revenue 1296
EBITDA 184
Net Income 162
ROA 15.7
P/Bk Ratio 22.79
ROE 24.84
FCFF 48.68
FCFF Yield 0.31

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 440.29 305.79 43.98% 408.00 311.07 31.16% 387.52 295.47 31.15% 383.20 284.70 34.60%
Expenses 363.30 290.74 24.96% 355.46 258.31 37.61% 349.45 228.23 53.11% 333.81 224.86 48.45%
EBITDA 76.99 15.05 411.56% 52.54 52.76 -0.42% 38.07 67.24 -43.38% 49.39 59.85 -17.48%
EBIDTM 17.49% 4.92% 12.88% 16.96% 9.82% 22.76% 12.89% 21.02%
Other Income 7.98 9.66 -17.39% 8.15 8.37 -2.63% 8.35 8.10 3.09% 8.73 8.00 9.12%
Interest 0.33 0.61 -45.90% 0.34 0.50 -32.00% 0.11 0.15 -26.67% 0.00 0.09 -100.00%
Depreciation 9.07 3.70 145.14% 9.32 3.68 153.26% 3.91 3.79 3.17% 3.76 4.25 -11.53%
PBT 42.02 20.40 105.98% 51.03 73.38 -30.46% -15.16 71.40 - 54.35 23.28 133.46%
Tax 11.17 4.60 142.83% 12.60 21.01 -40.03% -3.37 17.54 - 14.88 6.01 147.59%
PAT 30.85 15.80 95.25% 38.43 52.37 -26.62% -11.79 53.86 - 39.48 17.27 128.60%
PATM 7.01% 5.17% 9.42% 16.84% -3.04% 18.23% 10.30% 6.07%
EPS 12.34 6.32 95.25% 15.37 20.95 -26.63% -4.72 21.54 - 15.79 6.91 128.51%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,619.01 1,295.53 1,002.97 805.60 813.56 831.81 728.29 571.00 543.71 563.73 517.07 Net Sales Growth 35.25% 29.17% 24.50% -0.98% -2.19% 14.21% 27.55% 5.02% -3.55% 9.02% Cost Of Goods Sold 916.95 590.03 355.22 305.28 287.30 299.97 226.73 178.21 171.18 194.81 194.23 Gross Profit 702.06 705.50 647.75 500.32 526.26 531.84 501.56 392.79 372.53 368.93 322.84 GP Margin 43.36% 54.46% 64.58% 62.11% 64.69% 63.94% 68.87% 68.79% 68.52% 65.44% 62.44% Total Expenditure 1,402.02 1,111.08 837.85 719.42 678.09 711.11 656.99 524.71 506.77 547.31 528.48 Power & Fuel Cost - 4.87 5.54 8.10 7.37 7.72 8.27 8.30 7.68 7.43 8.51 % Of Sales - 0.38% 0.55% 1.01% 0.91% 0.93% 1.14% 1.45% 1.41% 1.32% 1.65% Employee Cost - 241.45 259.10 230.21 219.54 216.70 197.40 150.39 162.04 169.35 159.84 % Of Sales - 18.64% 25.83% 28.58% 26.99% 26.05% 27.10% 26.34% 29.80% 30.04% 30.91% Manufacturing Exp. - 89.46 76.04 57.12 49.32 40.81 49.58 50.67 36.40 25.82 17.69 % Of Sales - 6.91% 7.58% 7.09% 6.06% 4.91% 6.81% 8.87% 6.69% 4.58% 3.42% General & Admin Exp. - 66.30 56.66 40.04 40.69 65.54 74.09 46.49 55.04 59.10 63.77 % Of Sales - 5.12% 5.65% 4.97% 5.00% 7.88% 10.17% 8.14% 10.12% 10.48% 12.33% Selling & Distn. Exp. - 97.48 71.57 62.09 55.94 65.13 88.18 81.07 62.56 84.65 77.77 % Of Sales - 7.52% 7.14% 7.71% 6.88% 7.83% 12.11% 14.20% 11.51% 15.02% 15.04% Miscellaneous Exp. - 21.49 13.72 16.58 17.93 15.24 12.74 9.58 11.87 6.16 77.77 % Of Sales - 1.66% 1.37% 2.06% 2.20% 1.83% 1.75% 1.68% 2.18% 1.09% 1.29% EBITDA 216.99 184.45 165.12 86.18 135.47 120.70 71.30 46.29 36.94 16.42 -11.41 EBITDA Margin 13.40% 14.24% 16.46% 10.70% 16.65% 14.51% 9.79% 8.11% 6.79% 2.91% -2.21% Other Income 33.21 34.80 26.10 14.76 12.84 12.99 16.29 12.25 14.39 6.77 5.85 Interest 0.78 1.20 0.63 0.95 1.09 1.14 0.00 0.00 0.00 0.00 0.00 Depreciation 26.06 14.94 16.26 16.95 20.13 18.58 14.92 14.74 15.83 17.43 15.28 PBT 132.24 203.11 174.33 83.04 127.09 113.97 72.67 43.80 35.50 5.76 -20.84 Tax 35.28 58.03 34.81 21.44 33.79 41.76 18.22 17.89 15.45 0.50 0.00 Tax Rate 26.68% 26.43% 25.96% 25.82% 26.59% 36.64% 25.07% 40.84% 43.52% 8.68% 0.00% PAT 96.97 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 5.26 -20.84 PAT before Minority Interest 96.97 161.51 99.29 61.60 93.30 72.21 54.45 25.91 20.05 5.26 -20.84 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.99% 12.47% 9.90% 7.65% 11.47% 8.68% 7.48% 4.54% 3.69% 0.93% -4.03% PAT Growth -30.39% 62.66% 61.19% -33.98% 29.21% 32.62% 110.15% 29.23% 281.18% - EPS 38.79 64.60 39.72 24.64 37.32 28.88 21.78 10.36 8.02 2.10 -8.34

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 711.92 588.69 511.39 456.17 364.44 300.80 246.93 222.87 156.01 150.76 Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Total Reserves 703.63 581.12 504.44 449.58 357.85 293.70 239.85 216.22 151.01 145.76 Non-Current Liabilities 97.83 68.99 73.63 44.60 44.13 22.75 109.73 88.68 38.96 1.02 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 116.30 85.97 84.91 50.50 49.47 46.11 142.28 128.90 37.70 0.00 Current Liabilities 467.15 484.40 392.30 373.43 367.10 267.60 218.67 202.05 234.05 259.82 Trade Payables 196.51 227.88 190.44 178.37 209.72 168.20 127.20 87.66 94.63 111.27 Other Current Liabilities 110.53 111.95 94.23 82.58 71.06 54.38 39.41 69.84 121.08 111.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 160.11 144.57 107.63 112.48 86.32 45.02 52.06 44.55 18.33 36.95 Total Liabilities 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60 429.02 411.60 Net Block 66.68 68.86 74.49 80.96 71.53 74.83 75.46 86.84 97.36 100.99 Gross Block 187.13 179.12 168.83 159.78 132.84 119.83 105.85 102.57 203.76 191.44 Accumulated Depreciation 120.45 110.26 94.34 78.82 61.31 45.00 30.39 15.73 106.40 90.46 Non Current Assets 234.16 206.14 212.00 185.51 193.49 177.81 242.69 250.34 161.95 148.33 Capital Work in Progress 0.27 1.33 2.20 4.02 24.24 6.90 3.57 4.81 6.31 12.21 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 167.21 135.95 135.31 100.52 97.71 95.83 163.39 158.27 57.68 34.55 Other Non Current Assets 0.00 0.00 0.00 0.01 0.01 0.25 0.27 0.42 0.61 0.59 Current Assets 1,042.74 935.94 765.32 688.69 582.18 413.34 332.64 263.26 267.07 263.26 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 227.88 190.21 140.22 159.80 165.15 118.10 113.15 57.71 76.73 86.13 Sundry Debtors 153.13 107.52 85.89 85.19 83.21 79.75 54.63 43.00 83.14 42.77 Cash & Bank 505.84 500.48 448.46 352.35 252.52 173.30 125.92 115.58 76.83 25.08 Other Current Assets 155.89 13.56 12.64 14.05 81.30 42.19 38.94 46.97 30.37 109.27 Short Term Loans & Adv. 142.66 124.17 78.11 77.30 61.45 29.25 30.87 23.43 20.22 107.46 Net Current Assets 575.59 451.54 373.02 315.26 215.08 145.74 113.97 61.21 33.03 3.44 Total Assets 1,276.90 1,142.08 977.32 874.20 775.67 591.15 575.33 513.60 429.02 411.59

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 27.87 58.29 100.80 104.78 87.42 54.98 8.79 38.10 56.99 -45.70 PBT 219.54 134.10 83.04 127.09 113.97 72.67 43.80 35.50 5.76 -20.84 Adjustment -7.07 -4.80 9.66 14.20 9.75 7.62 3.39 14.61 12.11 8.58 Changes in Working Capital -128.17 -30.19 32.89 -3.95 -2.66 9.81 -34.25 -0.24 42.09 -32.58 Cash after chg. in Working capital 84.30 99.11 125.59 137.34 121.06 90.10 12.94 49.87 59.97 -44.83 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -56.43 -40.82 -24.79 -32.56 -33.64 -35.12 -4.15 -11.77 -2.98 -0.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 21.74 18.11 4.74 173.03 -170.80 4.28 -9.36 0.25 -3.61 -18.64 Net Fixed Assets -6.95 -9.42 -7.23 -6.72 -30.35 -17.31 -2.04 102.69 -6.42 -24.59 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 28.69 27.53 11.97 179.75 -140.45 21.59 -7.32 -102.44 2.81 5.95 Cash from Financing Activity -44.38 -24.48 -9.46 -8.97 -6.36 0.00 0.00 0.00 -0.51 0.00 Net Cash Inflow / Outflow 5.23 51.92 96.08 268.84 -89.74 59.26 -0.57 38.35 52.87 -64.34 Opening Cash & Equivalents 500.34 448.42 352.34 83.50 173.24 113.98 114.55 76.20 23.33 87.68 Closing Cash & Equivalent 505.57 500.34 448.42 352.34 83.50 173.24 113.98 114.55 76.20 23.33

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 283.45 234.45 203.78 181.83 145.14 119.48 97.94 88.49 62.41 60.30 ROA 13.35% 9.37% 6.65% 11.31% 10.57% 9.34% 4.76% 4.25% 1.25% -5.04% ROE 24.95% 18.13% 12.78% 22.83% 21.83% 20.03% 11.12% 10.63% 3.43% -12.93% ROCE 33.94% 24.49% 17.36% 31.24% 34.61% 26.53% 18.65% 18.74% 3.76% -12.93% Fixed Asset Turnover 7.11 5.79 4.93 5.58 6.58 6.45 5.49 3.58 2.88 2.91 Receivable days 36.53 35.03 38.57 37.62 35.75 33.67 31.15 41.96 40.32 33.27 Inventory Days 58.60 59.85 67.64 72.59 62.15 57.95 54.51 44.72 52.15 63.23 Payable days 131.27 214.92 220.48 246.52 99.66 91.40 73.21 75.53 75.14 85.66 Cash Conversion Cycle -36.14 -120.04 -114.26 -136.32 -1.76 0.22 12.45 11.15 17.33 10.84 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 183.95 213.86 88.41 117.60 100.97 0.00 0.00 0.00 0.00 0.00

Top Investors:

nippon life (various schemes)

tejas bhalchandra trivedi

shivani tejas trivedi

icici prudential (various schemes)

investor education and protection fund (iepf)

Annual Reports:

News Update:

AstraZeneca Pharma to launch Breztri Aerosphere in January 2025
19th Nov 2024, 09:25 AM

In December 2023, the company had received import and market permission in Form CT-20 from the Drugs Controller General of India for Breztri Aerosphere
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback